C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan

Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes...

Full description

Saved in:
Bibliographic Details
Published in:Cancer discovery 2022-11, Vol.12 (11), p.2509-2515
Main Authors: Kohno, Takashi, Kato, Mamoru, Kohsaka, Shinji, Sudo, Tomohisa, Tamai, Ikuo, Shiraishi, Yuichi, Okuma, Yusuke, Ogasawara, Daisuke, Suzuki, Tatsuya, Yoshida, Teruhiko, Mano, Hiroyuki
Format: Article
Language:English
Subjects:
Genomic Medicine
Genomics
Humans
Japan
Neoplasms - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3
cites cdi_FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3
container_end_page 2515
container_issue 11
container_start_page 2509
container_title Cancer discovery
container_volume 12
creator Kohno, Takashi
Kato, Mamoru
Kohsaka, Shinji
Sudo, Tomohisa
Tamai, Ikuo
Shiraishi, Yuichi
Okuma, Yusuke
Ogasawara, Daisuke
Suzuki, Tatsuya
Yoshida, Teruhiko
Mano, Hiroyuki
description Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes as of July 1, 2022) and established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), the national datacenter for CGM. Clinical information and genomic data from the CGP tests are securely transferred to C-CAT, which then generates "C-CAT Findings" reports containing information of clinical annotation and matched clinical trials based on the CGP data. As of June 30, 2022, a total of 36,340 datapoints of clinical/genomic information are aggregated in C-CAT, and the number is expected to increase swiftly. The data are now open for sharing with not only the CGM hospitals but also other academic institutions and industries.
doi_str_mv 10.1158/2159-8290.CD-22-0417
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9762342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2731429228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBCIotI_QMhHLil-JY45IFUpFFCBSzlbjuNQo9QudorE35OoJYK97Gofs6MZAC4wmmKc5tcEpyLJiUDTYp4QkiCG-RE4G9rHQ83ZCExi_EBdMMFSxE_BiGaUYIrSM1AUSTFb3cDV2sAX1VrvVAPnqlXauNYEWPsAC-V0Vy6M8xur4bOprLbOQOvgk9oqdw5OatVEMznkMXi7v1sVD8nydfFYzJaJZpy1iSZcZTlLteZ1XpmyzgQxRgtEOcpKRDKMda0orjRCWois41ubKq8ESqkuy5KOwe0ed7srN6bqGQbVyG2wGxW-pVdW_p84u5bv_ksKnhHKSAdwdQAI_nNnYis3NmrTNMoZv4uScIoZEYTk3Srbr-rgYwymHt5gJHsLZK-v7LWWxVwSInsLurPLvxSHo1_B6Q9w04D4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2731429228</pqid></control><display><type>article</type><title>C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan</title><source>Free E-Journal (出版社公開部分のみ）</source><creator>Kohno, Takashi ; Kato, Mamoru ; Kohsaka, Shinji ; Sudo, Tomohisa ; Tamai, Ikuo ; Shiraishi, Yuichi ; Okuma, Yusuke ; Ogasawara, Daisuke ; Suzuki, Tatsuya ; Yoshida, Teruhiko ; Mano, Hiroyuki</creator><creatorcontrib>Kohno, Takashi ; Kato, Mamoru ; Kohsaka, Shinji ; Sudo, Tomohisa ; Tamai, Ikuo ; Shiraishi, Yuichi ; Okuma, Yusuke ; Ogasawara, Daisuke ; Suzuki, Tatsuya ; Yoshida, Teruhiko ; Mano, Hiroyuki</creatorcontrib><description>Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes as of July 1, 2022) and established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), the national datacenter for CGM. Clinical information and genomic data from the CGP tests are securely transferred to C-CAT, which then generates "C-CAT Findings" reports containing information of clinical annotation and matched clinical trials based on the CGP data. As of June 30, 2022, a total of 36,340 datapoints of clinical/genomic information are aggregated in C-CAT, and the number is expected to increase swiftly. The data are now open for sharing with not only the CGM hospitals but also other academic institutions and industries.</description><identifier>ISSN: 2159-8274</identifier><identifier>EISSN: 2159-8290</identifier><identifier>DOI: 10.1158/2159-8290.CD-22-0417</identifier><identifier>PMID: 36321305</identifier><language>eng</language><publisher>United States: American Association for Cancer Research</publisher><subject>Genomic Medicine ; Genomics ; Humans ; Japan ; Neoplasms - genetics</subject><ispartof>Cancer discovery, 2022-11, Vol.12 (11), p.2509-2515</ispartof><rights>2022 The Authors; Published by the American Association for Cancer Research.</rights><rights>2022 The Authors; Published by the American Association for Cancer Research 2022 American Association for Cancer Research</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3</citedby><cites>FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3</cites><orcidid>0000-0001-6144-5845 ; 0000-0003-4645-0181 ; 0000-0003-1607-3899 ; 0000-0002-0100-9678 ; 0000-0001-8750-3097 ; 0000-0002-8485-8316 ; 0000-0002-5371-706X ; 0000-0003-0798-9176 ; 0000-0001-8773-6763 ; 0000-0001-5743-0149 ; 0000-0001-8651-6136</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36321305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kohno, Takashi</creatorcontrib><creatorcontrib>Kato, Mamoru</creatorcontrib><creatorcontrib>Kohsaka, Shinji</creatorcontrib><creatorcontrib>Sudo, Tomohisa</creatorcontrib><creatorcontrib>Tamai, Ikuo</creatorcontrib><creatorcontrib>Shiraishi, Yuichi</creatorcontrib><creatorcontrib>Okuma, Yusuke</creatorcontrib><creatorcontrib>Ogasawara, Daisuke</creatorcontrib><creatorcontrib>Suzuki, Tatsuya</creatorcontrib><creatorcontrib>Yoshida, Teruhiko</creatorcontrib><creatorcontrib>Mano, Hiroyuki</creatorcontrib><title>C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan</title><title>Cancer discovery</title><addtitle>Cancer Discov</addtitle><description>Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes as of July 1, 2022) and established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), the national datacenter for CGM. Clinical information and genomic data from the CGP tests are securely transferred to C-CAT, which then generates "C-CAT Findings" reports containing information of clinical annotation and matched clinical trials based on the CGP data. As of June 30, 2022, a total of 36,340 datapoints of clinical/genomic information are aggregated in C-CAT, and the number is expected to increase swiftly. The data are now open for sharing with not only the CGM hospitals but also other academic institutions and industries.</description><subject>Genomic Medicine</subject><subject>Genomics</subject><subject>Humans</subject><subject>Japan</subject><subject>Neoplasms - genetics</subject><issn>2159-8274</issn><issn>2159-8290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVUctOwzAQtBCIotI_QMhHLil-JY45IFUpFFCBSzlbjuNQo9QudorE35OoJYK97Gofs6MZAC4wmmKc5tcEpyLJiUDTYp4QkiCG-RE4G9rHQ83ZCExi_EBdMMFSxE_BiGaUYIrSM1AUSTFb3cDV2sAX1VrvVAPnqlXauNYEWPsAC-V0Vy6M8xur4bOprLbOQOvgk9oqdw5OatVEMznkMXi7v1sVD8nydfFYzJaJZpy1iSZcZTlLteZ1XpmyzgQxRgtEOcpKRDKMda0orjRCWois41ubKq8ESqkuy5KOwe0ed7srN6bqGQbVyG2wGxW-pVdW_p84u5bv_ksKnhHKSAdwdQAI_nNnYis3NmrTNMoZv4uScIoZEYTk3Srbr-rgYwymHt5gJHsLZK-v7LWWxVwSInsLurPLvxSHo1_B6Q9w04D4</recordid><startdate>20221102</startdate><enddate>20221102</enddate><creator>Kohno, Takashi</creator><creator>Kato, Mamoru</creator><creator>Kohsaka, Shinji</creator><creator>Sudo, Tomohisa</creator><creator>Tamai, Ikuo</creator><creator>Shiraishi, Yuichi</creator><creator>Okuma, Yusuke</creator><creator>Ogasawara, Daisuke</creator><creator>Suzuki, Tatsuya</creator><creator>Yoshida, Teruhiko</creator><creator>Mano, Hiroyuki</creator><general>American Association for Cancer Research</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6144-5845</orcidid><orcidid>https://orcid.org/0000-0003-4645-0181</orcidid><orcidid>https://orcid.org/0000-0003-1607-3899</orcidid><orcidid>https://orcid.org/0000-0002-0100-9678</orcidid><orcidid>https://orcid.org/0000-0001-8750-3097</orcidid><orcidid>https://orcid.org/0000-0002-8485-8316</orcidid><orcidid>https://orcid.org/0000-0002-5371-706X</orcidid><orcidid>https://orcid.org/0000-0003-0798-9176</orcidid><orcidid>https://orcid.org/0000-0001-8773-6763</orcidid><orcidid>https://orcid.org/0000-0001-5743-0149</orcidid><orcidid>https://orcid.org/0000-0001-8651-6136</orcidid></search><sort><creationdate>20221102</creationdate><title>C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan</title><author>Kohno, Takashi ; Kato, Mamoru ; Kohsaka, Shinji ; Sudo, Tomohisa ; Tamai, Ikuo ; Shiraishi, Yuichi ; Okuma, Yusuke ; Ogasawara, Daisuke ; Suzuki, Tatsuya ; Yoshida, Teruhiko ; Mano, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Genomic Medicine</topic><topic>Genomics</topic><topic>Humans</topic><topic>Japan</topic><topic>Neoplasms - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Kohno, Takashi</creatorcontrib><creatorcontrib>Kato, Mamoru</creatorcontrib><creatorcontrib>Kohsaka, Shinji</creatorcontrib><creatorcontrib>Sudo, Tomohisa</creatorcontrib><creatorcontrib>Tamai, Ikuo</creatorcontrib><creatorcontrib>Shiraishi, Yuichi</creatorcontrib><creatorcontrib>Okuma, Yusuke</creatorcontrib><creatorcontrib>Ogasawara, Daisuke</creatorcontrib><creatorcontrib>Suzuki, Tatsuya</creatorcontrib><creatorcontrib>Yoshida, Teruhiko</creatorcontrib><creatorcontrib>Mano, Hiroyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kohno, Takashi</au><au>Kato, Mamoru</au><au>Kohsaka, Shinji</au><au>Sudo, Tomohisa</au><au>Tamai, Ikuo</au><au>Shiraishi, Yuichi</au><au>Okuma, Yusuke</au><au>Ogasawara, Daisuke</au><au>Suzuki, Tatsuya</au><au>Yoshida, Teruhiko</au><au>Mano, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan</atitle><jtitle>Cancer discovery</jtitle><addtitle>Cancer Discov</addtitle><date>2022-11-02</date><risdate>2022</risdate><volume>12</volume><issue>11</issue><spage>2509</spage><epage>2515</epage><pages>2509-2515</pages><issn>2159-8274</issn><eissn>2159-8290</eissn><abstract>Since June 2019, under the umbrella of the national health insurance system, Japan has started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests. The Ministry of Health, Labour and Welfare (MHLW) of Japan constructed a network of CGM hospitals (a total of 233 institutes as of July 1, 2022) and established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), the national datacenter for CGM. Clinical information and genomic data from the CGP tests are securely transferred to C-CAT, which then generates "C-CAT Findings" reports containing information of clinical annotation and matched clinical trials based on the CGP data. As of June 30, 2022, a total of 36,340 datapoints of clinical/genomic information are aggregated in C-CAT, and the number is expected to increase swiftly. The data are now open for sharing with not only the CGM hospitals but also other academic institutions and industries.</abstract><cop>United States</cop><pub>American Association for Cancer Research</pub><pmid>36321305</pmid><doi>10.1158/2159-8290.CD-22-0417</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6144-5845</orcidid><orcidid>https://orcid.org/0000-0003-4645-0181</orcidid><orcidid>https://orcid.org/0000-0003-1607-3899</orcidid><orcidid>https://orcid.org/0000-0002-0100-9678</orcidid><orcidid>https://orcid.org/0000-0001-8750-3097</orcidid><orcidid>https://orcid.org/0000-0002-8485-8316</orcidid><orcidid>https://orcid.org/0000-0002-5371-706X</orcidid><orcidid>https://orcid.org/0000-0003-0798-9176</orcidid><orcidid>https://orcid.org/0000-0001-8773-6763</orcidid><orcidid>https://orcid.org/0000-0001-5743-0149</orcidid><orcidid>https://orcid.org/0000-0001-8651-6136</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2159-8274
ispartof Cancer discovery, 2022-11, Vol.12 (11), p.2509-2515
issn 2159-8274
2159-8290
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9762342
source Free E-Journal (出版社公開部分のみ）
subjects Genomic Medicine
Genomics
Humans
Japan
Neoplasms - genetics
title C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=C-CAT:%20The%20National%20Datacenter%20for%20Cancer%20Genomic%20Medicine%20in%20Japan&rft.jtitle=Cancer%20discovery&rft.au=Kohno,%20Takashi&rft.date=2022-11-02&rft.volume=12&rft.issue=11&rft.spage=2509&rft.epage=2515&rft.pages=2509-2515&rft.issn=2159-8274&rft.eissn=2159-8290&rft_id=info:doi/10.1158/2159-8290.CD-22-0417&rft_dat=%3Cproquest_pubme%3E2731429228%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-c27a6845cc7f8debf692eec903706b02611cfa31dc00c996004fed8d9053cbbb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2731429228&rft_id=info:pmid/36321305&rfr_iscdi=true